The PI3K/AKT/mTOR (mammalian target of rapamycin) signalling pathway regulates cell growth, survival, motility, metabolism, and angiogenesis, and its activation contributes to tumor development and resistance to anticancer therapy38. Here, MTOR is linked to neoplasm.